Expert Interviews

Evaluating efficacy, safety of intracameral dexamethasone 9% vs topical regimen for cataract surgery

Robert Weinstock, MD, discusses the efficacy and safety of intracameral dexamethasone suspension 9% compared to standard of care topical regimen for eyes receiving cataract surgery.

Evaluating dexamethasone intraocular suspension 9% post-cataract surgery

Cathleen McCabe, MD, shares an overview of results from a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.

ViaLase CEO talks innovations in glaucoma treatment

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.